News & Events
News & Events
December 17, 2018
CPTR Newsletter – December 2018CPTR Newsletter – December 2018 In this issue: In the Spotlight: TB-ReFLECT Manuscript Published Updates to the TB-PACTS Clinical Trial Data Repository Project Highlights: Application of the HFS-TB to Inform Regimen Development Programs Collaboration to Expand ReSeqTB Clinical Data Sets Supporting Global Surveillance of TB Resistance Progress with Regulatory Authorities LAM Biomarker Notes...
April 26, 2018
CPTR Newsletter – April 2018CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collaborations Expand TB-PACTS Database and Leverage Data for Analyses CPTR Workgroup Works to Advance Regulatory Qualification of LAM, a Promising New Biomarker TB-PBPK Model Progresses Toward EMA and FDA Qualification TB-ReFLECT Update: A Collaborative Effort...
March 24, 2018
Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant TuberculosisWHO adopts ReSeqTB as bioinformatics platform for TB surveillance, enabling the global scale-up of culture-free, drug-resistant Mycobacterium tuberculosis surveillance programs based on sequencing technologies Renewed funding from the Bill & Melinda Gates Foundation has been applied for to support FIND, C-Path, and WHO to take ReSeqTB to the next level as part...
February 5, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponedCritical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Workshop (CPTR) 2018 Annual workshop originally scheduled for April 23-25, 2018. This workshop will be rescheduled later in 2018 to better align with deliverables from our programmatic efforts and alleviate some of the logistical challenges...
May 1, 2017
Critical Path Institute and TGen Forge Partnership to Advance TB ResearchMay 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1, 2017 – The Critical Path to TB Drug Regimens (CPTR), an initiative of the Critical Path Institute (C-Path), has received a $1.1 million grant from the Bill & Melinda Gates Foundation to significantly enrich its...